Clinical Trial Update: A Study to Assess the Effect of Y-90 Therapy on Non-target/Background Liver [NA]

View source ↗

Summary

A terminated clinical trial assessing the effect of Y-90 therapy on non-target/background liver tissue in hepatocellular carcinoma and liver cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Cancer

Drugs mentioned

• Y-90 therapy (yttrium-90 radiotherapy)

Snippet

Sponsor: Indiana University | Conditions: HCC, Liver Cancer | NA | Status: TERMINATED | Results posted: 2020-09-25